The challenged biotech firm, NovaGen Therapeutics, faced severe fiscal difficulties stemming from disappointing clinical trials and growing debt. Their internal team lacked the experience to manage the https://emilielkzu560477.mpeblog.com/74302972/biotech-cfo-services-a-case-study-in-monetary-restructuring